Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CDK4 antibody (N-Term)

The Rabbit Monoclonal anti-CDK4 antibody is suitable to detect CDK4 in samples from Human. It has been validated for WB and IHC.
Catalog No. ABIN7865043
$640.46
Plus shipping costs $50.00
Shipping to: United States
Delivery in 2 to 5 Business Days

Quick Overview for Recombinant CDK4 antibody (N-Term) (ABIN7865043)

Target

See all CDK4 Antibodies
CDK4 (Cyclin-Dependent Kinase 4 (CDK4))

Antibody Type

Recombinant Antibody

Reactivity

  • 163
  • 81
  • 65
  • 19
  • 8
  • 6
  • 5
  • 4
  • 3
  • 1
  • 1
  • 1
Human

Host

  • 134
  • 47
  • 2
Rabbit

Clonality

  • 94
  • 88
Monoclonal

Conjugate

  • 113
  • 11
  • 9
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CDK4 antibody is un-conjugated

Application

  • 143
  • 62
  • 48
  • 47
  • 43
  • 39
  • 22
  • 21
  • 14
  • 13
  • 6
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)

Clone

CDK4-8210R
  • Binding Specificity

    • 18
    • 16
    • 15
    • 14
    • 9
    • 8
    • 8
    • 7
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Purpose

    Recombinant CDK4 Antibody

    Specificity

    Cyclin-dependent kinase-4 (CDK4) is a protein-serine kinase involved in the cell cycle. It is essential for the G1- to S-phase transition during the cell cycle and its expression is primarily controlled at the transcriptional level (PMID:17253961). CCND1- CDK4 axis is not only critical in glial tumor cells but also in stromal-derived cells in the surrounding tumor microenvironment that are vital to sustain tumor outgrowth (PMID:21844184). CDK4 is highly expressed in highly differentiated and dedifferentiated liposarcomas, but rarely expressed in other benign liposarcomas and other sarcomas. CDK4 and MDM2 combined to differentiate between highly differentiated liposarcoma (+), dedifferentiated liposarcoma (+) and myxoid liposarcoma, pleomorphic liposarcoma, spindle lipoma, pleomorphic lipoma and other high-grade sarcomas.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment corresponding to N-terminal of human CDK4 protein

    Isotype

    IgG, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Target

    CDK4 (Cyclin-Dependent Kinase 4 (CDK4))

    Alternative Name

    CDK4

    Background

    CDK4 protein, CDK4_HUMAN, Cell division protein kinase 4, CMM3, Crk3, Cyclin dependent kinase 4, Melanoma cutaneous malignant 3, MGC14458, p34 cdk4, PSK-J3

    MCF7, HEK293T, cervical carcinoma and liposarcomas.|Human urothelial carcinoma, K-562

    Molecular Weight

    34kDa

    Gene ID

    1019, 95577

    UniProt

    P11802

    Pathways

    Cell Division Cycle, Mitotic G1-G1/S Phases, Regulation of Cell Size
You are here:
Chat with us!